TrialsgrambetaRCTs are beautiful

DOREMI

2021

Milrinone versus Dobutamine in Cardiogenic Shock

In 192 patients with cardiogenic shock, milrinone produced similar rates of death and major complications compared with dobutamine.

Result

Primary endpoint: Composite of death, resuscitated arrest, mechanical support and other events

No significant difference between the two inotropes.

Original publication
Subtopic
Inotropes
Design
Double-blind RCT
Relevance
Supporting: context rather than must-know.
Source
Mathew R, et al. N Engl J Med. 2021;385(6):516-525.doi 10.1056/NEJMoa2026845

Discussion & critique

No winning inotrope in cardiogenic shock: the choice is by patient characteristics and side-effect profile, not outcomes.

Discussed in podcasts